Skip to main content
NCBI home page
Heart logoLink to Heart
. 2000 Nov;84(5):567–572. doi: 10.1136/heart.84.5.567

Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery

C Gohlke-Barwolf
PMCID: PMC1729481  PMID: 11040023

Full Text

The Full Text of this article is available as a PDF (115.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol. 1998 Nov;32(5):1486–1588. doi: 10.1016/s0735-1097(98)00454-9. [DOI] [PubMed] [Google Scholar]
  2. Acar J., Iung B., Boissel J. P., Samama M. M., Michel P. L., Teppe J. P., Pony J. C., Breton H. L., Thomas D., Isnard R. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation. 1996 Nov 1;94(9):2107–2112. doi: 10.1161/01.cir.94.9.2107. [DOI] [PubMed] [Google Scholar]
  3. Cannegieter S. C., Rosendaal F. R., Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994 Feb;89(2):635–641. doi: 10.1161/01.cir.89.2.635. [DOI] [PubMed] [Google Scholar]
  4. Cannegieter S. C., Rosendaal F. R., Wintzen A. R., van der Meer F. J., Vandenbroucke J. P., Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995 Jul 6;333(1):11–17. doi: 10.1056/NEJM199507063330103. [DOI] [PubMed] [Google Scholar]
  5. Carrel T. P., Klingenmann W., Mohacsi P. J., Berdat P., Althaus U. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis. 1999 Jul;8(4):392–398. [PubMed] [Google Scholar]
  6. Gohlke-Bärwolf C., Acar J., Oakley C., Butchart E., Burckhart D., Bodnar E., Hall R., Delahaye J. P., Horstkotte D., Krémer R. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 1995 Oct;16(10):1320–1330. doi: 10.1093/oxfordjournals.eurheartj.a060739. [DOI] [PubMed] [Google Scholar]
  7. Montalescot G., Polle V., Collet J. P., Leprince P., Bellanger A., Gandjbakhch I., Thomas D. Low molecular weight heparin after mechanical heart valve replacement. Circulation. 2000 Mar 14;101(10):1083–1086. doi: 10.1161/01.cir.101.10.1083. [DOI] [PubMed] [Google Scholar]
  8. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994 Nov 19;344(8934):1383–1389. [PubMed] [Google Scholar]
  9. Sawicki P. T. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA. 1999 Jan 13;281(2):145–150. doi: 10.1001/jama.281.2.145. [DOI] [PubMed] [Google Scholar]
  10. Shetty H. G., Backhouse G., Bentley D. P., Routledge P. A. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1. Thromb Haemost. 1992 Jan 23;67(1):13–15. [PubMed] [Google Scholar]
  11. Turpie A. G., Gent M., Laupacis A., Latour Y., Gunstensen J., Basile F., Klimek M., Hirsh J. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993 Aug 19;329(8):524–529. doi: 10.1056/NEJM199308193290802. [DOI] [PubMed] [Google Scholar]
  12. Wahl M. J. Dental surgery in anticoagulated patients. Arch Intern Med. 1998 Aug 10;158(15):1610–1616. doi: 10.1001/archinte.158.15.1610. [DOI] [PubMed] [Google Scholar]
  13. Weibert R. T., Le D. T., Kayser S. R., Rapaport S. I. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med. 1997 Jun 15;126(12):959–962. doi: 10.7326/0003-4819-126-12-199706150-00005. [DOI] [PubMed] [Google Scholar]
  14. White R. H., McKittrick T., Hutchinson R., Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med. 1995 Jan 1;122(1):40–42. doi: 10.7326/0003-4819-122-1-199501010-00006. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Additional references]
heart_84_5_567__index.html (3.8KB, html)
[Correction to Table 3]
heart_84_5_567_v2_index.html (4.5KB, html)

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES